Home / Methylprednisolone / United States
US ATC D07AA01 · updated 2 Nov 2026
Methylprednisolone shortage in United States
Is there a Methylprednisolone shortage in United States?
Yes. As of 2 Nov 2026, 22 Methylprednisolone products are reported short in United States, the first since 15 Dec 2021. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) | Pfizer Inc. | 15 Dec 2021 | not given | Not stated |
| US | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) | Pfizer Inc. | 15 Dec 2021 | not given | Increased demand Demand increase for the drug |
| US | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) limited | Pfizer Inc. | 15 Dec 2021 | not given | Other |
| US | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) limited | Pfizer Inc. | 15 Dec 2021 | not given | Increased demand Demand increase for the drug |
| US | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) | Pfizer Inc. | 15 Dec 2021 | not given | Not stated |
| US | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) limited | Pfizer Inc. | 15 Dec 2021 | not given | Increased demand Demand increase for the drug |
| US | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) limited | Pfizer Inc. | 15 Dec 2021 | not given | Other |
| US | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) | Pfizer Inc. | 15 Dec 2021 | not given | Not stated |
| US | Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) | Pfizer Inc. | 15 Dec 2021 | not given | Not stated |
| US | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) | Pfizer Inc. | 15 Dec 2021 | not given | Not stated |
| US | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) | Pfizer Inc. | 15 Dec 2021 | not given | Not stated |
| US | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) limited | Pfizer Inc. | 15 Dec 2021 | not given | Increased demand Demand increase for the drug |
| US | Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) limited | Pfizer Inc. | 15 Dec 2021 | not given | Other |
| US | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) | Sagent Pharmaceuticals | 15 Dec 2021 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) limited | Sagent Pharmaceuticals | 15 Dec 2021 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) | Eugia US LLC | 15 Dec 2021 | not given | Increased demand Demand increase for the drug |
| US | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1) limited | Amneal Pharmaceuticals | 15 Dec 2021 | not given | Other |
| US | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5) | Amneal Pharmaceuticals | 15 Dec 2021 | not given | Not stated |
| US | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) limited | Sagent Pharmaceuticals | 15 Dec 2021 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) | Eugia US LLC | 15 Dec 2021 | not given | Increased demand Demand increase for the drug |
| US | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1) | Amneal Pharmaceuticals | 15 Dec 2021 | not given | Not stated |
| US | Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5) | Amneal Pharmaceuticals | 15 Dec 2021 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).